Key facts
- Inspire’s last known valuation is $136.3M (Jun 2023).
- It has raised $68.2M; the latest was Later Stage VC ($10.0M) in Sep 2025.
- Notable investors include Azoic Ventures, Tenfore Holdings, Viscogliosi Bros..
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Inspire
- ·The full record, as it builds
Funding rounds
No funding rounds for Inspire are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inspire
Operator Developer of a health data platform intended to connect patients and researchers for medical discovery. The company's platform offers patient communities and data-sharing capabilities, enabling researchers and healthcare organizations to advance discoveries through real-world patient insights.
- Sector
- Healthcare
- HQ
- Arlington, VA, United States
- Founded
- 2005
- Employees
- 80
- Website
- inspireresearch.com/
- Ownership
- Privately Held (backing)
Inspire doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inspire shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inspire in its N-PORT filings yet. We sweep new filings monthly.